WY, P., A, A., SM, Z., R, M., KS, W., XH, L., . . . FH, S. (2026). Cost-effectiveness of various referral pathways to identify advanced fibrosis among type 2 diabetes mellitus patients with metabolic dysfunction-associated steatotic liver disease in primary care setting in Malaysia. PloS one, 21(5), e0350263. https://doi.org/10.1371/journal.pone.0350263
Chicago Style (17th ed.) CitationWY, Poh, Azzeri A, Zain SM, Mohamed R, Wan KS, Lee XH, Dahlui M, and Shabaruddin FH. "Cost-effectiveness of Various Referral Pathways to Identify Advanced Fibrosis Among Type 2 Diabetes Mellitus Patients with Metabolic Dysfunction-associated Steatotic Liver Disease in Primary Care Setting in Malaysia." PloS One 21, no. 5 (2026): e0350263. https://doi.org/10.1371/journal.pone.0350263.
MLA (9th ed.) CitationWY, Poh, et al. "Cost-effectiveness of Various Referral Pathways to Identify Advanced Fibrosis Among Type 2 Diabetes Mellitus Patients with Metabolic Dysfunction-associated Steatotic Liver Disease in Primary Care Setting in Malaysia." PloS One, vol. 21, no. 5, 2026, p. e0350263, https://doi.org/10.1371/journal.pone.0350263.
